US Stocks
BCLI
Brainstorm Cell Therapeutics Inc.
$0.7171
+0.0221 (+3.18%)
Volume:
6.808K ($4.88K)
Market Capitalization:
-
Brainstorm Cell Therapeutics Price Chart
Brainstorm Cell Therapeutics Volume Chart
Brainstorm Cell Therapeutics Market Segments
Regular Trading Hours
+0.0171(+2.44%)
| Open | $0.7000 |
|---|---|
| Close | $0.7171 |
| Low | $0.7000 |
| Low Change | 0.0000 (0.00%) |
| High | $0.7171 |
| High Change | +0.0171 (+2.44%) |
| Range | $0.0171 |
| Volume | 6.808K |
| Dollar Volume | $4.88K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.0950(+15.83%)
| Open | $0.6000 |
|---|---|
| Close | $0.6950 |
| Low | $0.5950 |
| Low Change | -0.0050 (-0.83%) |
| High | $0.7000 |
| High Change | +0.1000 (+16.67%) |
| Range | $0.1050 |
| Volume | 9.616K |
| Dollar Volume | $6.68K |
Premarket Yesterday
*No Trades in Segment
Brainstorm Cell Therapeutics Statistics
| Average Volume (30 Days) | 21.35K |
|---|---|
| P/E Ratio (Current) | -.53 |
| EPS (Current) | -$1.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$9.49M |
| Cash Ratio | 0.10 |
| Current Ratio | 0.18 |
| Quick Ratio | 0.18 |
| Debt to Equity | -0.02 |
| Enterprise Value | $5.38M |
| EV to EBITDA | -0.46 |
| EV to Sales | — |
| Price to Book | -1.01 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -4.46% |
| Return on Equity | 1.89% |
Brainstorm Cell Therapeutics Stock Splits
There have been 2 stock splits for Brainstorm Cell Therapeutics (BCLI). The last reverse stock split occured on October 1, 2024 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| October 1, 2024 | Reverse | 15:1 |
| September 16, 2014 | Reverse | 15:1 |